Shopping Cart
- Remove All
- Your shopping cart is currently empty
MK-912 is a potent novel selective alpha2-adrenergic receptor antagonist with oral activity to study the effect of short-term selective alpha2-blockers on fasting glucose (FPG) and islet function in non-insulin-dependent patients with diabetes mellitus (NIDDM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $6,350 | 6-8 weeks |
Description | MK-912 is a potent novel selective alpha2-adrenergic receptor antagonist with oral activity to study the effect of short-term selective alpha2-blockers on fasting glucose (FPG) and islet function in non-insulin-dependent patients with diabetes mellitus (N |
Alias | MK912, MK 912 |
Molecular Weight | 375.89 |
Formula | C20H26ClN3O2 |
Cas No. | 119942-70-0 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.